Novel immunotherapy approach to treat cat allergy: High levels of adjuvant molecule found to boost immune tolerance to major cat allergen and mitigate allergy symptoms – Science Daily

Researchers from the Department of Infection and Immunity of the Luxembourg Institute of Health (LIH) brought forward the potential of high doses of a specific adjuvant molecule, namely CpG oligonucleotide, in successfully modulating the immune system’s allergic response to the main cat allergen Fel d 1, thereby inducing a tolerance-promoting reaction and reverting the main hallmarks of cat allergy. The researchers analysed the molecular mechanisms underlying this tolerance and proposed a pre-clinical…

Click here to view the original article.